A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...

Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

In response to a parliamentary query, the ministry said that the Department of Pharmaceuticals, through the National ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

The trial comes as a new study highlighted differences in how genes are activated in brain tumour cells compared to healthy ones.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Glioblastoma is the most common type of brain tumour in the UK and it is unique to each individual, making it extremely hard ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Colombian President Gustavo Petro claims cocaine is no worse than alcohol, arguing its illegality is due to its origin in ...